enVVeno Medical Corporation NVNO
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.73M | 8.66M | 10.17M | 10.62M | 11.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.74M | 17.38M | 19.71M | 20.60M | 22.95M |
| Operating Income | -16.74M | -17.38M | -19.71M | -20.60M | -22.95M |
| Income Before Tax | -15.55M | -15.72M | -18.82M | -19.47M | -21.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.55 | -15.72 | -18.82 | -19.47 | -21.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.55M | -15.72M | -18.82M | -19.47M | -21.97M |
| EBIT | -16.74M | -17.38M | -19.71M | -20.60M | -22.95M |
| EBITDA | -16.63M | -17.26M | -19.58M | -20.46M | -22.81M |
| EPS Basic | -23.60 | -25.20 | -31.35 | -33.22 | -37.85 |
| Normalized Basic EPS | -15.76 | -17.12 | -19.97 | -21.20 | -23.91 |
| EPS Diluted | -23.60 | -25.20 | -31.35 | -33.22 | -37.85 |
| Normalized Diluted EPS | -15.76 | -17.12 | -19.97 | -21.20 | -23.91 |
| Average Basic Shares Outstanding | 2.64M | 2.52M | 2.43M | 2.35M | 2.32M |
| Average Diluted Shares Outstanding | 2.64M | 2.52M | 2.43M | 2.35M | 2.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |